ZYLOX-TONBRIDGE Made Exclusive Technology Collaboration with SKY ROAD to Enrich its Product Portfolio

Hangzhou, China, 15 November 2021- Zylox-Tonbridge (2190.HK, the "Company") announced the Company has signed a collaboration agreement with Sky Road. Under the agreement, Sky Road has granted to the Company an exclusive license regarding certain proprietary technology for developing Intravascular Lithotripsy (IVL) system for the treatment of peripheral vascular disease. The collaboration will allow Zylox-Tonbridge to enrich the product portfolio for peripheral vascular medical devices, providing doctors and patients more effective and comprehensive solutions.

Sky Road is a China based medical device company focusing on energy based medical device technology. The IVL system technology developed by Sky Road with pending global patent protections will allow Zylox-Tonbridge to develop IVL system for the treatment of medium and heavy calcified arteries, and the data and performance based on the demo system have demonstrated its safety and efficacy. The system includes IVL generator, IVL connector cable, IVL PTA balloon catheter and IVL enhanced drug-eluting balloon catheter, which are the latest additions to our total solution management for lower limb artery diseases. The Company will continue to develop more products and enhance Zylox-Tonbridge's leadership position as a total solution provider to physicians for bringing effective treatments and improving quality of life of patients.

Pursuant to the collaboration agreement, Zylox-Tonbridge is entitled to develop, manufacture and commercialize the IVL system worldwide, and Sky Road is in return entitled to certain economic interests such as upfront, milestone payments and sales royalty.

Jonathon Zhao, Founder, Chairman, and CEO of Zylox-Tonbridge, remarked, "As one of the leading players in the field of peripheral vascular devices, Zylox-Tonbridge, one of the leading peripheral vascular device companies, has always committed itself to providing advanced and innovative products. The collaboration with Sky Road will allow the Company to provide doctors and patients with effective total solutions, enhancing our leadership in China’s peripheral vascular intervention medical device market.”

Sky Road commented, “As one of the innovative neurovascular medical device companies in energy-based medical devices, we are very excited about the collaboration with Zylox-Tonbridge. We believe the strong Research, Development, Manufacturing and commercialization capability and strength of Zylox-Tonbridge will bring our IVL system and comprehensive solutions to patients quickly in near future."